wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37601188-1467F38E-0D97-4ABB-AB9E-15BD946E2844
Q37601188-1467F38E-0D97-4ABB-AB9E-15BD946E2844
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37601188-1467F38E-0D97-4ABB-AB9E-15BD946E2844
Difference in the effects of switching from candesartan to olmesartan or telmisartan to olmesartan in hypertensive patients with type 2 diabetes: the COTO study
P2860
Q37601188-1467F38E-0D97-4ABB-AB9E-15BD946E2844
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37601188-1467F38E-0D97-4ABB-AB9E-15BD946E2844
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
837718f26b0f9e2f7ae7ba89dcecbfb3e2ec03d8
P2860
Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.